TimeScale Financial’s Gilead Sciences GILD Stock Holding History

TimeScale Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.77K	Hold	23	–	–	﹤0.01%	505
2023 Q1	$1.91K	Hold	23	–	–	﹤0.01%	490
2022 Q4	$1.42K	Hold	23	–	–	﹤0.01%	478
2022 Q3	$1K	Hold	23	–	–	﹤0.01%	500
2022 Q2	$1K	Hold	23	–	–	﹤0.01%	468
2022 Q1	$1K	Hold	23	–	–	﹤0.01%	487
2021 Q4	$2K	Hold	23	–	–	﹤0.01%	439
2021 Q3	$2K	Hold	23	–	–	﹤0.01%	432
2021 Q2	$2K	Hold	23	–	–	﹤0.01%	435
2021 Q1	$1K	Hold	23	–	–	﹤0.01%	467
2020 Q4	$1K	Hold	23	–	–	﹤0.01%	397
2020 Q3	$1K	Buy	+23	New	+$1.59K	﹤0.01%	420

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TimeScale Financial's GILD Position: Q2 2023 in Review

TimeScale Financial held its Gilead Sciences (GILD) position steady in Q2 2023 at 23 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

TimeScale Financial first reported a position in GILD in Q3 2020 and has held it in 12 quarters since. The position peaked at $2K in Q4 2021. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

TimeScale Financial held 23 shares of Gilead Sciences worth $1.77K as of Q2 2023.
TimeScale Financial left its Gilead Sciences share count unchanged in Q2 2023.
Gilead Sciences made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #505 holding.
TimeScale Financial first reported a position in Gilead Sciences in Q3 2020 and has held it in 12 quarters since.
TimeScale Financial's Gilead Sciences position peaked at $2K in Q4 2021.
1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.